CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Juno (psychedelic)

pharmaceutical compound

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionFeb 21, 2026
Entity authorityQ136799012 ↗
Source-derived summary

Juno, also known as 4,6-dimethyl-2,5-dimethoxyamphetamine or as 6-methyl-DOM, is a possible psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOM. It is the 6-methyl derivative of DOM and a positional isomer of Ganesha (3-methyl-DOM). The drug is one of Alexander Shulgin's "ten classic ladies", a series of methylated DOM derivatives. DOM, Ganesha, and DOTMA (Julia; 3,6-dimethyl-DOM) are all known to be active psychedelics, so Juno is expected to be an active psychedelic as well, but has not yet been tested. Juno was first described by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). He shared in PiHKAL that he had had Juno on a shelf in his lab for almost 14 years but had never gotten around to trying it. It is a controlled substance in Canada under phenethylamine blanket-ban language.

Editorial summary

“Juno (psychedelic)” enters the record as pharmaceutical compound. Crown Archives preserves that source wording while asking what Juno, psychedelic and pharmaceutical can confirm, complicate or overturn.

Editorial reviewA practical starting point whose main value is the path it opens into stronger specialist and primary sources. The current lead gives the account dated anchors—1991—that can be checked directly. The selected authority fields contribute no independent date. Its strongest next move is a source search built around Juno, psychedelic and pharmaceutical.
Editorial analysis

Why this record matters

“Juno (psychedelic)” is worth following because a concise public description often conceals a longer documentary argument. Here, Juno, psychedelic and pharmaceutical provides the most credible route into that argument.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Feb 21, 2026. The linked authority identifier is Q136799012. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1991.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Juno (psychedelic)”, its source revision and the description used here.
  2. Expand the search: follow Juno (psychedelic) primary sources, Juno (psychedelic) archive and Juno research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Juno (psychedelic)”?
  2. What terminology or title could unlock a more precise catalogue search?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Juno (psychedelic)” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.